Contact
Please use this form to send email to PR contact of this press release:
Kura Oncology Granted U.S. Patent for Clinical-Stage ERK Inhibitor, KO-947
TO:
Please use this form to send email to PR contact of this press release:
Kura Oncology Granted U.S. Patent for Clinical-Stage ERK Inhibitor, KO-947
TO: